UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
SPARTA SURGICAL CORPORATION
(Name of Issuer)
$.002 Par Value Common Stock
(Title of Class of Securities)
846648 88 9
(CUSIP Number)
Thomas F. Reiner, 7068 Koll Center Pkwy #401, Pleasanton, CA 94566,(510)417-8812
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
February 25, 1998
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [ ]. (A
fee is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 4 pages
<PAGE>
CUSIP No. 846648 88 9
Schedule 13D
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Numbers of Above
Persons
Thomas F. Reiner
S.S. Number ###-##-####
(2) Check the Appropriate Box if a (a) [ ]
Member of a Group (See Instructions) (b) [ ]
(3) SEC Use Only
(4) Source of Funds (See Instructions)
Not Applicable
(5) Check Box if Disclosure of Legal Proceedings
is Required Pursuant to Items 2(d) or 2(e) [ ]
(6) Citizenship or Place of Organization
United States
(7) Sole Voting Power 1,567,484
Number of Shares
Beneficially Owned (8) Shared Voting Power 0
by Each Reporting
Person With (9) Sole Dispositive Power 1,431,233
(10) Shared Dispositive Power 0
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
1,567,484
(12) Check Box if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions) [ ]
(13) Percent of Class Represented by Amount in Row (11)
65.24%
(14) Type of Reporting Person (See Instructions)
Individual - IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 4 pages
<PAGE>
Item 1. Security and Issuer
This statement relates to the issuance of 647,986 shares (the "Shares")
of Common Stock, $0.002 par value of Sparta Surgical Corporation (the
"Issuer"), whose principal executive offices are located at Bernal
Corporate Park, 7068 Koll Center Parkway, Suite 401, Pleasanton, CA
94566 to Thomas F. Reiner ( the "Reporting Person").
Item 2. Identity and Background
(a) Thomas F. Reiner.
(b) 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566.
(c) President, Chief Executive Officer and Chairman of the Board of
Sparta Surgical Corporation, 7068 Koll Center Parkway, Suite 401,
Pleasanton, California 94566.
(d) No.
(e) No.
(f) United States.
Item 3. Source and Amount of Funds or Other Consideration
Not Applicable.
Item 4. Purpose of Transaction
Not Applicable.
Item 5. Interest in Securities of the Issuer
(a) Following the issuance of the Shares as to which this schedule
pertains, the Reporting Person is the Beneficial Owner of 1,567,484
shares of Common Stock (by direct ownership of 782,148 shares of Common
Stock including 10,417 shares which the Reporting Person has voting
rights and the right to acquire 785,336 including shares as which the
Reporting Person will have voting rights following the exercise of
125,834 warrants held by others.) This equates to voting control and/or
ownership over approximately 65.24% of the Issuer's outstanding Common
Stock.
(b) The Reporting Person has the right to vote all of the shares
referenced in Item 5 (a) and to direct the disposition of all but
136,251 of such shares.
Page 3 of 4 pages
<PAGE>
(c) None.
(d) None.
(e) Not Applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to
Securities of the Issuer
Not Applicable.
Item 7. Material to Be Filed as Exhibits
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
March 6, 1998
--------------------
Dated
/s/ Thomas F. Reiner
--------------------
Thomas F. Reiner
Page 4 of 4 pages
